HealthLynked Appoints Insurance Industry Veterans to Board as Company Prepares for Nasdaq Listing

HealthLynked Corp. (OTCQB: HLYK) has appointed two insurance industry veterans to its Board of Directors as the company prepares for a planned listing on the Nasdaq Capital Market. The AI-driven global healthcare network announced the appointments of Chris G. Pulos from Marsh McLennan Agency and Jason Bishara from NSI Insurance Group, bringing what the company describes as decades of combined experience in employer benefits, payer strategy, insurance and risk management.

Founder and CEO Dr. Michael Dent stated that the new board members' expertise will be instrumental in supporting the national scaling of the HealthLynked Network and its AI platform, ARI. The appointments come as HealthLynked expands its collaborations with insurers, employer groups and healthcare organizations, with Dent emphasizing that their knowledge will also strengthen corporate governance ahead of the planned market listing. The company's platform is designed to improve care coordination and reduce healthcare costs through personalized care management.

HealthLynked's cloud-based platform connects patients with healthcare providers for both virtual and in-office appointments while consolidating medical records into a single secure location. The system utilizes AI-driven insights and integrated telehealth services to help patients and providers coordinate care more effectively while delivering what the company claims are substantial savings on prescriptions and healthcare services. The platform supports enterprise partnerships, offering scalable solutions to healthcare networks and digital health innovators seeking to improve outcomes while controlling costs.

The company's latest news and updates are available through its newsroom at https://ibn.fm/HLYLK. The full press release announcing the board appointments can be viewed at https://ibn.fm/QbV7l. HealthLynked operates in the competitive healthcare technology sector where coordination between insurers, providers and patients remains a significant challenge, and the company's strategy appears focused on leveraging industry expertise to navigate complex payer relationships as it expands its market presence.